4-Chlororesorcinol → 2',4,5,6,7-pentachloro-3',6'-dihydroxy-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one

HRID 41611

반응식

HRID 41611 반응식
[Cl:1][C:2]1[C:3]([Cl:15])=[C:4]([Cl:14])[C:5]([Cl:13])=[C:6]2[C:11](=O)[O:10][C:8](=[O:9])[C:7]=12.[Cl:16][C:17]1[CH:23]=[CH:22][C:20]([OH:21])=[CH:19][C:18]=1[OH:24].[C:25]1([CH:32]=[CH:31][CH:30]=[C:28](O)[CH:27]=1)[OH:26]>>[Cl:16][C:17]1[C:18]([OH:24])=[CH:19][C:20]2[O:21][C:31]3[C:30](=[CH:28][CH:27]=[C:25]([OH:26])[CH:32]=3)[C:11]3([C:6]4[C:7](=[C:2]([Cl:1])[C:3]([Cl:15])=[C:4]([Cl:14])[C:5]=4[Cl:13])[C:8](=[O:9])[O:10]3)[C:22]=2[CH:23]=1

참가 물질

4

반응물 3

HCID 17314-ChlororesorcinolHCID 5054ResorcinolHCID 8326Tetrachlorophthalic anhydride

생성물 1

HCID 670433342',4,5,6,7-pentachloro-3',6'-dihydroxy-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one수율 82.1%

실험 절차

Treatment of tetrachlorophthalic anhydride (5 g, 17.48 mmol), 4-chlororesorcinol (2.78 g, 19.23 mmol) and resorcinol (2.12 g, 19.23 mmol) according to the procedure described in Example 1 Step 1 provided 7.24 g of 18.6% pure 2′,4,5,6,7-pentachloro-3′,6′-dihydroxy-3H-spiro[isobenzofuran-1,9′-xanthen]-3-one that was collected and taken to the next step as a mixture.

출처 및 근거

ORD 기록
ord-efe7a51ec05d4fed8e48641bb82b8010
출처 데이터셋
uspto-grants-2013_09
특허 번호
US08530675B2

연결된 노트

불러오는 중…